SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615219-21-000008
Filing Date
2021-01-21
Accepted
2021-01-21 08:00:19
Documents
3
Period of Report
2021-01-21
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K salarius-8xk01212021nasdaq.htm 8-K 23972
2 EX-99.1 salarius-minimumbidrequire.htm EX-99.1 11006
3 image_11.jpg GRAPHIC 39936
  Complete submission text file 0001615219-21-000008.txt   91237
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 21540396
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences